Filtros de búsqueda

Lista de obras de

10% Tumor diameter shrinkage on the first follow-up computed tomography predicts clinical outcome in patients with advanced renal cell carcinoma treated with angiogenesis inhibitors: a follow-up validation study

artículo científico publicado en 2014

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

artículo científico publicado en 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

artículo científico publicado en 2016

A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis

artículo científico publicado en 2019

A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations.

artículo científico publicado en 2017

A Randomized Phase II Study of AGS-16C3F Versus Axitinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma

artículo científico publicado en 2020

A case of adult metastatic Xp11 translocation renal cell carcinoma treated successfully with sunitinib

artículo científico publicado en 2009

A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma

artículo científico publicado en 2019

A model that predicts the probability of positive imaging in prostate cancer cases with biochemical failure after initial definitive local therapy

artículo científico publicado en 2008

A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma

artículo científico publicado en 2014

A phase 1 study of buparlisib and bevacizumab in patients with metastatic renal cell carcinoma progressing on vascular endothelial growth factor-targeted therapies

artículo científico publicado en 2016

A phase 2, single-arm study of ramucirumab in patients with metastatic renal cell carcinoma with disease progression on or intolerance to tyrosine kinase inhibitor therapy.

artículo científico publicado en 2014

A population-based overview of sequences of targeted therapy in metastatic renal cell carcinoma.

artículo científico publicado en 2013

A systematic review and meta-analysis of adjuvant and neoadjuvant chemotherapy for upper tract urothelial carcinoma

artículo científico

ABO blood group alleles and prostate cancer risk: Results from the breast and prostate cancer cohort consortium (BPC3).

artículo científico publicado en 2015

Abiraterone Acetate Induces CREB1 Phosphorylation and Enhances the Function of the CBP-p300 Complex, Leading to Resistance in Prostate Cancer Cells

artículo científico publicado en 2021

Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib

artículo científico publicado en 2014

Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted Therapies

artículo científico publicado en 2018

Activity of cabozantinib after immune checkpoint blockade in metastatic clear-cell renal cell carcinoma

artículo científico publicado en 2020

Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer

scientific article published on 15 November 2019

Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.

artículo científico

Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial

artículo científico

Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis

artículo científico publicado en 2018

Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials

artículo científico publicado en 2013

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial

artículo científico publicado en 2016

Adoption of immunotherapy in the community for patients diagnosed with metastatic melanoma

scientific article published on 07 November 2019

Adrenocortical carcinoma: the management of metastatic disease

artículo científico publicado en 2014

An Open Label Phase Ib Dose Escalation Study of TRC105 (Anti-Endoglin Antibody) with Axitinib in Patients with Metastatic Renal Cell Carcinoma

scientific article published on 06 September 2018

An association between renal cell carcinoma and multiple myeloma: a case series and clinical implications

artículo científico publicado en 2007

An evaluation of the 'weekend effect' in patients admitted with metastatic prostate cancer.

artículo científico publicado en 2014

An overview of targeted treatments in cancer ⬇️

artículo científico publicado el 1 de agosto de 2003

Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies

artículo científico publicado en 2013

Analysis of Response Data for Assessing Treatment Effects in Comparative Clinical Studies

artículo científico publicado en 2020

Androgen Deprivation Therapy and Overall Survival for Gleason 8 Versus Gleason 9-10 Prostate Cancer

artículo científico publicado en 2018

Androgen-suppression therapy for prostate cancer and the risk of death in men with a history of myocardial infarction or stroke

artículo científico publicado en 2010

Angiogenesis inhibitor therapies for metastatic renal cell carcinoma: effectiveness, safety and treatment patterns in clinical practice-based on medical chart review.

artículo científico publicado en 2009

Angiogenic and immune-related biomarkers and outcomes following axitinib/pembrolizumab treatment in patients with advanced renal cell carcinoma

scientific article published on 18 August 2020

Angiotensin system inhibitors and survival outcomes in patients with metastatic renal cell carcinoma.

artículo científico publicado en 2015

Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2).

artículo científico publicado en 2018

Arterial thromboembolism in cancer patients treated with cisplatin: a systematic review and meta-analysis

artículo científico

Asian Americans and prostate cancer: A nationwide population-based analysis.

artículo científico publicado en 2015

Assessing the Contemporary Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma: Another Step in the Right Direction

artículo científico publicado en 2015

Assessment of Treatment Patterns for Metastatic Renal Cell Carcinoma in Brazil.

artículo científico publicado en 2017

Association Between Older Age and Increasing Gleason Score

artículo científico publicado en 2015

Association between very small tumour size and increased cancer-specific mortality after radical prostatectomy in lymph node-positive prostate cancer

artículo científico publicado en 2015

Association of Androgen Deprivation Therapy With Depression in Localized Prostate Cancer

artículo científico publicado en 2016

Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.

artículo científico publicado en 2011

Association of androgen-deprivation therapy with excess cardiac-specific mortality in men with prostate cancer.

artículo científico publicado en 2014

Association of tumour microRNA profiling with outcomes in patients with advanced urothelial carcinoma receiving first-line platinum-based chemotherapy

artículo científico publicado en 2016

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

scientific article published on 09 May 2019

Author Correction: Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes

artículo científico publicado en 2020

Autoimmune Arthropathy and Uveitis as Complications of Programmed Death 1 Inhibitor Treatment

artículo científico publicado en 2016

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

artículo científico publicado en 2019

Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial

artículo científico publicado en 2020

Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101

artículo científico publicado en 2020

Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial.

artículo científico publicado en 2018

Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial

scientific article published on 04 January 2021

BRAF mutations in metanephric adenoma of the kidney

artículo científico publicado en 2012

Biomarker analysis from CheckMate 214: nivolumab plus ipilimumab versus sunitinib in renal cell carcinoma

artículo científico publicado en 2022

Biomarker-Based Phase II Trial of Savolitinib in Patients With Advanced Papillary Renal Cell Cancer

artículo científico publicado en 2017

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations

artículo científico publicado en 2016

Burden of hospital admissions and utilization of hospice care in metastatic prostate cancer patients.

artículo científico publicado en 2015

COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma

artículo científico publicado en 2019

COVID-19 and Cancer: Current Challenges and Perspectives

artículo científico publicado en 2020

Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trial.

artículo científico publicado en 2016

Cabozantinib Versus Sunitinib for Untreated Patients with Advanced Renal Cell Carcinoma of Intermediate or Poor Risk: Subgroup Analysis of the Alliance A031203 CABOSUN trial

scientific article published on 09 August 2019

Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study

artículo científico publicado en 2019

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma

artículo científico publicado en 2015

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial.

artículo científico publicado en 2016

Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update.

artículo científico publicado en 2018

Cabozantinib, a New Standard of Care for Patients With Advanced Renal Cell Carcinoma and Bone Metastases? Subgroup Analysis of the METEOR Trial.

artículo científico publicado en 2018

Cancer Care Disparities during the COVID-19 Pandemic: COVID-19 and Cancer Outcomes Study

artículo científico publicado en 2020

Cancer-specific mortality of Asian Americans diagnosed with cancer: a nationwide population-based assessment

artículo científico publicado en 2015

Cancer-specific outcomes among young adults without health insurance

artículo científico publicado en 2014

Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy

artículo científico publicado en 2010

Carbonic anhydrase IX as a potential biomarker of efficacy in metastatic clear-cell renal cell carcinoma patients receiving sorafenib or placebo: analysis from the treatment approaches in renal cancer global evaluation trial (TARGET).

artículo científico publicado en 2012

Change in Neutrophil-to-lymphocyte Ratio in Response to Targeted Therapy for Metastatic Renal Cell Carcinoma as a Prognosticator and Biomarker of Efficacy.

artículo científico publicado en 2016

Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma.

artículo científico publicado en 2018

Characteristics of long-term and short-term survivors of metastatic renal cell carcinoma treated with targeted therapies: results from the International mRCC Database Consortium

artículo científico publicado en 2014

Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling

artículo científico publicado en 2017

Characterization of Clinical Cases of Collecting Duct Carcinoma of the Kidney Assessed by Comprehensive Genomic Profiling

artículo científico publicado en 2015

Characterization of Patients With Poor-Risk Metastatic Renal-Cell Carcinoma: Results From a Pooled Clinical Trials Database

artículo científico publicado en 2017

Characterizing the impact of lymph node metastases on the survival outcome for metastatic renal cell carcinoma patients treated with targeted therapies.

artículo científico publicado en 2014

Characterizing the outcomes of metastatic papillary renal cell carcinoma

artículo científico publicado en 2017

Characterizing trends in treatment modalities for localized muscle-invasive bladder cancer in the pre-immunotherapy era

artículo científico publicado en 2018

Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the international metastatic renal cell carcinoma database consortium

artículo científico publicado en 2018

ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma

artículo científico publicado en 2014

Clinical Outcomes of First-line Sunitinib Followed by Immuno-oncology Checkpoint Inhibitors in Patients With Metastatic Renal Cell Carcinoma

artículo científico publicado en 2019

Clinical Validation of PBRM1 Alterations as a Marker of Immune Checkpoint Inhibitor Response in Renal Cell Carcinoma

scientific article published on 05 September 2019

Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

artículo científico publicado en 2018

Clinical and Genomic Characterization of Low-Prostate-specific Antigen, High-grade Prostate Cancer.

artículo científico publicado en 2018

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy.

artículo científico publicado en 2007

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

artículo científico publicado en 2020

Clinical outcome in metastatic renal cell carcinoma patients after failure of initial vascular endothelial growth factor-targeted therapy

artículo científico publicado en 2010

Clinical risk factors for the development of hypertension in patients treated with inhibitors of the VEGF signaling pathway.

artículo científico publicado en 2014

Cognitive Impairment in Men with Prostate Cancer Treated with Androgen Deprivation Therapy: A Systematic Review and Meta-Analysis

artículo científico publicado en 2018

Comorbidity, body mass index, and age and the risk of nonprostate-cancer-specific mortality after a postradiation prostate-specific antigen recurrence

scientific article published on 01 February 2010

Comparative Effectiveness of Radical Prostatectomy Versus External Beam Radiation Therapy Plus Brachytherapy in Patients with High-risk Localized Prostate Cancer

artículo científico publicado en 2018

Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder

artículo científico publicado en 2017

Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample

artículo científico publicado en 2012

Comparative effectiveness of robot-assisted and open radical prostatectomy in the postdissemination era.

artículo científico publicado en 2014

Comparative effectiveness of robot-assisted vs. open radical cystectomy

artículo científico publicado en 2017

Comparative effectiveness, costs and trends in treatment of small renal masses from 2005 to 2007.

artículo científico publicado en 2013

Comparing the Association Between Insurance and Mortality in Ovarian, Pancreatic, Lung, Colorectal, Prostate, and Breast Cancers

scientific article published on 01 September 2019

Comparison of Gonadotropin-Releasing Hormone Agonists and Orchiectomy: Effects of Androgen-Deprivation Therapy.

artículo científico publicado en 2015

Comparison of four early posttherapy imaging changes (EPTIC; RECIST 1.0, tumor shrinkage, computed tomography tumor density, Choi criteria) in assessing outcome to vascular endothelial growth factor-targeted therapy in patients with advanced renal c

artículo científico publicado en 2011

Complete response as an intermediate end point in patients receiving salvage systemic therapy for urothelial carcinoma.

artículo científico publicado en 2014

Complications After Metastasectomy for Renal Cell Carcinoma-A Population-based Assessment

artículo científico publicado en 2017

Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.

artículo científico publicado en 2017

Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell Carcinoma.

artículo científico publicado en 2018

Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients.

artículo científico publicado en 2017

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma

artículo científico publicado en 2015

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma

artículo científico publicado en 2016

Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma

article

Conditional immune toxicity rate in patients with metastatic renal and urothelial cancer treated with immune checkpoint inhibitors

artículo científico publicado en 2020

Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study.

artículo científico publicado en 2012

Congestive heart failure risk in patients with breast cancer treated with bevacizumab.

artículo científico publicado en 2011

Congestive heart failure with vascular endothelial growth factor receptor tyrosine kinase inhibitors

artículo científico

Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Cancer.

artículo científico publicado en 2017

Contemporary national trends in prostate cancer risk profile at diagnosis

scientific article published on 24 June 2019

Contemporary nationwide patterns of self-reported prostate-specific antigen screening in US veterans.

artículo científico publicado en 2015

Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States.

scientific article published on 22 July 2015

Correlation Between Molecular Subclassifications of Clear Cell Renal Cell Carcinoma and Targeted Therapy Response.

artículo científico publicado en 2015

Correlation of Apobec Mrna Expression with overall Survival and pd-l1 Expression in Urothelial Carcinoma

artículo científico publicado en 2016

Correlation of PD-L1 tumor expression and treatment outcomes in patients with renal cell carcinoma receiving sunitinib or pazopanib: results from COMPARZ, a randomized controlled trial

artículo científico publicado en 2014

Corrigendum re “Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma” [Eur Urol 2017;72:747–54]

scholarly article published in European Urology

Corrigendum to 'Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update

scientific article published on 27 September 2018

Cost implications and complications of overtreatment of low-risk prostate cancer in the United States

artículo científico publicado en 2015

Cost implications of IV versus oral anti-angiogenesis therapies in patients with advanced renal cell carcinoma: retrospective claims database analysis.

artículo científico publicado en 2009

Cost implications of the rapid adoption of newer technologies for treating prostate cancer

artículo científico publicado en 2011

Costs associated with angiogenesis inhibitor therapies for metastatic renal cell carcinoma in clinical practice: results from a medical chart review study

artículo científico publicado en 2010

Current Approaches to the Treatment of Advanced or Metastatic Renal Cell Carcinoma

scientific article published on 01 March 2020

Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

scientific article published on 05 April 2019

Cytoreductive nephrectomy in patients with metastatic non-clear-cell renal cell carcinoma (RCC)

artículo científico publicado en 2014

Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

artículo científico publicado en 2014

Data on Medicare eligibility and cancer screening utilization

artículo científico publicado en 2016

Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma

artículo científico publicado en 2020

Definition and Validation of "Favorable High-Risk Prostate Cancer": Implications for Personalizing Treatment of Radiation-Managed Patients

artículo científico publicado en 2015

Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma

artículo científico publicado en 2015

Detection of renal cell carcinoma using plasma and urine cell-free DNA methylomes

artículo científico publicado en 2020

Determinants of Prostate Specific Antigen Screening among Black Men in the United States in the Contemporary Era.

artículo científico publicado en 2015

Determinants of cancer screening in Asian-Americans.

artículo científico publicado en 2016

Determinants of performing radical prostatectomy pelvic lymph node dissection and the number of lymph nodes removed in elderly men.

artículo científico publicado en 2010

Diagnosis of Renal Cell Carcinoma: A Clinician's Perspective

artículo científico publicado en 2015

Differential Expression of PD-L1 between Primary and Metastatic Sites in Clear-Cell Renal Cell Carcinoma

artículo científico publicado en 2015

Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications

artículo científico publicado en 2017

Differential expression of c-Met between primary and metastatic sites in clear-cell renal cell carcinoma and its association with PD-L1 expression

artículo científico publicado en 2017

Differential post-prostatectomy cancer-specific survival of occult T3 vs. clinical T3 prostate cancer: Implications for managing patients upstaged on prostate magnetic resonance imaging.

artículo científico publicado en 2015

Differential side effects profile in patients with mCRPC treated with abiraterone or enzalutamide: a meta-analysis of randomized controlled trials.

artículo científico publicado en 2017

Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma.

artículo científico publicado en 2017

Disparities in selective referral for cancer surgeries: implications for the current healthcare delivery system

scientific article published on 23 March 2014

Disparities in the Receipt of Local Treatment of Node-positive Prostate Cancer

artículo científico publicado en 2016

Double-blind, randomized trial of docetaxel plus vandetanib versus docetaxel plus placebo in platinum-pretreated metastatic urothelial cancer

artículo científico publicado en 2011

Durable clinical benefit in metastatic renal cell carcinoma patients who discontinue PD-1/PD-L1 therapy for immune-related adverse events (irAEs).

artículo científico publicado en 2018

Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center

artículo científico publicado en 2015

ERCC1 as a prognostic factor for survival in patients with advanced urothelial cancer treated with platinum based chemotherapy: A systematic review and meta-analysis

artículo científico publicado en 2017

Effect of Antibiotic Use on Outcomes with Systemic Therapies in Metastatic Renal Cell Carcinoma

scientific article published on 24 September 2019

Effect of Metformin Use on Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma

artículo científico publicado en 2016

Effect of Nonurothelial Histologic Variants on the Outcomes of Radical Cystectomy for Nonmetastatic Muscle-invasive Urinary Bladder Cancer.

artículo científico publicado en 2017

Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma.

artículo científico publicado en 2017

Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA

scientific article published on 15 May 2018

Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-Line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma

artículo científico publicado en 2020

Efficacy and toxicity of sunitinib in patients with metastatic renal cell carcinoma with severe renal impairment or on haemodialysis

artículo científico publicado en 2011

Efficacy of High-Intensity Local Treatment for Metastatic Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Analysis From the National Cancer Data Base

artículo científico publicado en 2016

Efficacy of Local Treatment in Prostate Cancer Patients with Clinically Pelvic Lymph Node-positive Disease at Initial Diagnosis.

artículo científico publicado en 2017

Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma: The SAVOIR Phase 3 Randomized Clinical Trial

artículo científico publicado en 2020

Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Category

artículo científico publicado en 2016

Efficacy of Systemic Chemotherapy Plus Radical Nephroureterectomy for Metastatic Upper Tract Urothelial Carcinoma.

artículo científico publicado en 2016

Efficacy of sunitinib and sorafenib in metastatic papillary and chromophobe renal cell carcinoma

artículo científico publicado en 2008

Efficacy of targeted therapies after PD-1/PD-L1 blockade in metastatic renal cell carcinoma.

artículo científico publicado en 2015

Efficacy of targeted therapy for metastatic renal cell carcinoma in the elderly patient population.

artículo científico publicado en 2014

Elderly patients with metastatic renal cell carcinoma: position paper from the International Society of Geriatric Oncology

artículo científico publicado en 2018

Elicitation of health state utilities in metastatic renal cell carcinoma

artículo científico publicado en 2010

Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer

scientific article published on 21 November 2019

Endothelin receptor antagonists: rationale, clinical development, and role in prostate cancer therapeutics

scientific article published on 01 March 2006

Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

artículo científico publicado en 2017

Evaluating a Video-Based, Personalized Webpage in Genitourinary Oncology Clinical Trials: A Phase 2 Randomized Trial

scientific article published on 02 May 2019

Evaluation of disease-free survival as an intermediate metric of overall survival in patients with localized renal cell carcinoma: A trial-level meta-analysis

artículo científico publicado en 2017

Evaluation of the Safety and Efficacy of Immunotherapy Rechallenge in Patients With Renal Cell Carcinoma

artículo científico publicado en 2020

Evaluation of the contribution of demographics, access to health care, treatment, and tumor characteristics to racial differences in survival of advanced prostate cancer

artículo científico publicado en 2018

Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial

artículo científico publicado en 2015

Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma

scientific article published on 17 September 2018

Everolimus- and temsirolimus-associated enteritis: report of three cases.

artículo científico publicado en 2011

Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma

artículo científico publicado en 2017

Evolving Systemic Treatment Landscape for Patients With Advanced Renal Cell Carcinoma

artículo científico publicado en 2018

Evolving role of pegylated interferons in metastatic renal cell carcinoma

artículo científico publicado en 2003

Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma

artículo científico publicado en 2015

Expression of Ror2 mediates invasive phenotypes in renal cell carcinoma

artículo científico publicado en 2014

Expression of T-cell Exhaustion Molecules and Human Endogenous Retroviruses as Predictive Biomarkers for response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma

artículo científico publicado en 2020

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

artículo científico publicado en 2013

FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder

artículo científico publicado en 2014

Facility Level Variation in Rates of Definitive Therapy for Low Risk Prostate Cancer in Men with Limited Life Expectancy: An Opportunity for Value Based Care Redesign

scientific article published on 01 April 2019

Factors associated with the adoption of minimally invasive radical prostatectomy in the United States.

artículo científico publicado en 2012

Factors associated with the omission of androgen deprivation therapy in radiation-managed high-risk prostate cancer.

artículo científico publicado en 2016

Fatigue with vascular endothelial growth factor receptor tyrosine kinase inhibitors and mammalian target of rapamycin inhibitors in patients with renal cell carcinoma (RCC) and other malignancies: A meta-analysis of randomized clinical trials.

artículo científico

First-line Immuno-Oncology Combination Therapies in Metastatic Renal-cell Carcinoma: Results from the International Metastatic Renal-cell Carcinoma Database Consortium

artículo científico publicado en 2019

First-line Mammalian target of rapamycin inhibition in metastatic renal cell carcinoma: an analysis of practice patterns from the International Metastatic Renal Cell Carcinoma Database Consortium

artículo científico publicado en 2014

First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

artículo científico publicado en 2016

Five-Factor Prognostic Model for Survival of Post-Platinum Patients with Metastatic Urothelial Carcinoma Receiving PD-L1 Inhibitors

scientific article published on 18 June 2020

Future directions and targeted therapies in bladder cancer

artículo científico

Genetic Variants Related to Longer Telomere Length are Associated with Increased Risk of Renal Cell Carcinoma ⬇️

artículo científico publicado en 2017

Genome-wide association study identifies multiple risk loci for renal cell carcinoma ⬇️

artículo científico publicado en 2017

Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets

artículo científico publicado en 2015

Genomic correlates of response to immune checkpoint blockade in microsatellite-stable solid tumors

artículo científico publicado en 2018

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

artículo científico publicado en 2018

Genomic investigation of etiologic heterogeneity: methodologic challenges

artículo científico publicado en 2014

Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study

scientific article published on 08 November 2018

Geographic Distribution of Racial Differences in Prostate Cancer Mortality

scientific article published on 02 March 2020

Getting back to equal: The influence of insurance status on racial disparities in the treatment of African American men with high-risk prostate cancer.

artículo científico publicado en 2014

Gleason score 5 + 3 = 8 prostate cancer: much more like Gleason score 9?

artículo científico publicado en 2015

Gonadotropin-releasing hormone agonists and acute kidney injury in patients with prostate cancer

artículo científico publicado en 2014

HER2 as a target in invasive urothelial carcinoma

artículo científico publicado en 2015

Haematologic toxicities associated with the addition of bevacizumab in cancer patients

artículo científico publicado en 2011

Health care spending in prostate cancer: An assessment of characteristics and health care utilization of high resource-patients

scientific article published on 09 December 2020

Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer.

artículo científico publicado en 2018

Hematologic toxicities in cancer patients treated with the multi-tyrosine kinase sorafenib: a meta-analysis of clinical trials

artículo científico publicado en 2011

Hepatotoxicity with vascular endothelial growth factor receptor tyrosine kinase inhibitors: A meta-analysis of randomized clinical trials

artículo científico publicado en 2014

High Throughput Kinomic Profiling of Human Clear Cell Renal Cell Carcinoma Identifies Kinase Activity Dependent Molecular Subtypes

artículo científico publicado en 2015

Hypothyroidism During Tyrosine Kinase Inhibitor Therapy Is Associated with Longer Survival in Patients with Advanced Nonthyroidal Cancers.

artículo científico publicado en 2018

IL-8 and cancer prognosis on immunotherapy

scientific article published on 01 May 2020

Identification of ALK gene alterations in urothelial carcinoma

artículo científico publicado en 2014

Identification of comorbidities that place men at highest risk of death from androgen deprivation therapy before brachytherapy for prostate cancer

artículo científico publicado en 2013

Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

artículo científico publicado en 2016

Immunotherapy in the Elderly

artículo científico publicado en 2017

Impact of Geographic Regions on Overall Survival in Patients With Metastatic Renal Cell Carcinoma: Results From an International Clinical Trials Database

scientific article published on 01 September 2018

Impact of body composition on clinical outcomes in metastatic renal cell cancer

artículo científico publicado en 2011

Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy

artículo científico publicado en 2013

Impact of percent positive biopsy cores on cancer-specific mortality for patients with high-risk prostate cancer

artículo científico publicado en 2020

Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death.

artículo científico publicado en 2010

Impact of response to prior chemotherapy in patients with advanced urothelial carcinoma receiving second-line therapy: implications for trial design

artículo científico publicado en 2013

Impact of tumor, treatment, and access on outcomes in bladder cancer: Can equal access overcome race-based differences in survival?

scientific article published on 11 January 2019

Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial Carcinoma

artículo científico publicado en 2015

In Reply

Incidence and Predictors of Upgrading and Up Staging among 10,000 Contemporary Patients with Low Risk Prostate Cancer.

artículo científico publicado en 2015

Incidence and risk of congestive heart failure in patients with renal and nonrenal cell carcinoma treated with sunitinib.

artículo científico publicado en 2011

Incidence of Severe Nephrotoxicity With Cisplatin Based on Renal Function Eligibility Criteria: Indirect Comparison Meta-analysis

artículo científico

Income inequality and treatment of African American men with high-risk prostate cancer

artículo científico publicado en 2014

Incomplete Cross-Resistance Between Taxanes for Advanced Urothelial Carcinoma: Implications for Clinical Practice and Trial Design

artículo científico publicado en 2014

Increased Vulnerability to Poorer Cancer-Specific Outcomes Following Recent Divorce.

artículo científico publicado en 2018

Influence of Androgen Deprivation Therapy on All-Cause Mortality in Men With High-Risk Prostate Cancer and a History of Congestive Heart Failure or Myocardial Infarction

artículo científico publicado en 2011

Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma.

artículo científico publicado en 2014

Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma

artículo científico publicado en 2020

Intraobserver and interobserver variability in computed tomography size and attenuation measurements in patients with renal cell carcinoma receiving antiangiogenic therapy: implications for alternative response criteria

artículo científico publicado en 2013

Investigating the effect of treatment at high-volume hospitals on overall survival following cytoreductive nephrectomy

artículo científico publicado en 2018

JAVELIN: avelumab another spear to fight urothelial carcinoma.

artículo científico publicado en 2017

Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

artículo científico publicado en 2017

Kidney cancer

artículo científico publicado en 2011

Kidney cancer, version 2.2014.

artículo científico publicado en 2014

Kidney cancer, version 3.2015.

artículo científico publicado en 2015

Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period.

artículo científico publicado en 2014

Landscape of tumor-infiltrating T cell repertoire of human cancers

artículo científico publicado en 2016

Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationale

artículo científico publicado en 2019

Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study

artículo científico publicado en 2015

Liver Disease in Men Undergoing Androgen Deprivation Therapy for Prostate Cancer

artículo científico publicado en 2018

Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma.

artículo científico publicado en 2018

MET as a target in papillary renal cell carcinoma

artículo científico publicado en 2014

Mammalian SWI/SNF complex genomic alterations and immune checkpoint blockade in solid tumors

scientific article published on 22 April 2020

Marital status and survival in patients with cancer

artículo científico publicado en 2013

Markers of inflammation are associated with clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab.

artículo científico publicado en 2015

Mechanisms of acquired resistance to rapalogs in metastatic renal cell carcinoma

scientific article published on 26 September 2018

Mental health outcomes in elderly men with prostate cancer

artículo científico publicado en 2014

Meta-analysis of randomized controlled trials for the incidence and risk of treatment-related mortality in patients with cancer treated with vascular endothelial growth factor tyrosine kinase inhibitors.

artículo científico publicado en 2012

Metabolic complications with the use of mTOR inhibitors for cancer therapy

artículo científico publicado en 2013

Metabolomic adaptations and correlates of survival to immune checkpoint blockade

scientific article published on 25 September 2019

Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma

artículo científico publicado en 2010

Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteria

scientific article published on 21 May 2013

Metastatic renal cell carcinoma: Contending with a sea change in therapy

artículo científico publicado en 2015

Molecular Subtypes Improve Prognostic Value of International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Model

artículo científico publicado en 2017

Morbidity and Mortality of Locally Advanced Prostate Cancer: A Population Based Analysis Comparing Radical Prostatectomy versus External Beam Radiation

artículo científico publicado en 2017

Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma

artículo científico publicado en 2016

Mutational Analysis of 472 Urothelial Carcinoma Across Grades and Anatomic Sites

scientific article published on 28 December 2018

Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma

scientific article published on 25 October 2019

Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma

artículo científico publicado en 2016

NCCN Guidelines Insights: Kidney Cancer, Version 1.2021

artículo científico publicado en 2020

NCCN Guidelines Insights: Kidney Cancer, Version 2.2020

artículo científico publicado en 2019

NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy

artículo científico publicado en 2011

NCCN clinical practice guidelines in oncology: kidney cancer

article

NCCN clinical practice guidelines in oncology: testicular cancer

article

National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer

artículo científico publicado en 2017

National sociodemographic disparities in the treatment of high-risk prostate cancer: Do academic cancer centers perform better than community cancer centers?

artículo científico publicado en 2016

Neoadjuvant Androgen Deprivation Therapy Prior to Radical Prostatectomy: Recent Trends in Utilization and Association with Postoperative Surgical Margin Status

artículo científico publicado en 2018

Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates

scientific article published on 12 May 2014

Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology

artículo científico publicado en 2017

New therapies for castrate-resistant prostate cancer

artículo científico publicado en 2011

Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.

artículo científico publicado en 2018

Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial

scientific article published on 16 August 2019

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

artículo científico publicado en 2015

Nivolumab versus everolimus in patients with advanced renal cell carcinoma: Updated results with long-term follow-up of the randomized, open-label, phase 3 CheckMate 025 trial

artículo científico publicado en 2020

Nomogram to Assess the Survival Benefit of New Salvage Agents for Metastatic Urothelial Carcinoma in the Era of Immunotherapy

artículo científico publicado en 2018

Non-Clear Cell Renal Cell Carcinomas: From Shadow to Light

artículo científico publicado en 2018

Non-clear cell renal cancer: features and medical management

artículo científico publicado en 2009

Non-clear cell renal cell carcinoma, part 1: histology.

artículo científico

Non-clear cell renal cell carcinoma, part 2: therapy

artículo científico

Novel Therapeutic Approaches and the Evolution of Drug Development in Advanced Kidney Cancer

scientific article published on 01 September 2020

Occult High-risk Disease in Clinically Low-risk Prostate Cancer with ≥50% Positive Biopsy Cores: Should National Guidelines Stop Calling Them Low Risk?

artículo científico publicado en 2015

Optimisation of the size variation threshold for imaging evaluation of response in patients with platinum-refractory advanced transitional cell carcinoma of the urothelium treated with vinflunine

artículo científico publicado en 2011

Optimized Management of Nivolumab and Ipilimumab in Advanced Renal Cell Carcinoma: A Response-Based Phase II Study (OMNIVORE)

artículo científico publicado en 2020

Optimizing bone health and minimizing skeletal morbidity in men with prostate cancer

artículo científico publicado en 2013

Optimizing systemic therapy for metastatic renal cell carcinoma beyond the first-line setting

artículo científico publicado en 2015

Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium.

artículo científico publicado en 2014

Outcomes based on age in the phase III METEOR trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma

scientific article published on 27 December 2019

Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinoma

scientific article published on 10 September 2018

Outcomes in Black and White Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors: Insights From Two Large Cohorts

scientific article published on 01 February 2020

Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)

Outcomes of Patients with Metastatic Renal Cell Carcinoma Treated with Targeted Therapy After Immuno-oncology Checkpoint Inhibitors

scientific article published on 27 November 2019

Overall survival in renal-cell carcinoma with pazopanib versus sunitinib

artículo científico publicado en 2014

PD-1 blockade in renal cell carcinoma: to equilibrium and beyond

artículo científico publicado en 2014

PD-L1 Expression and Clinical Outcomes to Cabozantinib, Everolimus, and Sunitinib in Patients with Metastatic Renal Cell Carcinoma: Analysis of the Randomized Clinical Trials METEOR and CABOSUN

artículo científico publicado en 2019

Pan-urologic cancer genomic subtypes that transcend tissue of origin

artículo científico publicado en 2017

Pancreatitis with vascular endothelial growth factor receptor tyrosine kinase inhibitors

artículo científico

Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma.

artículo científico

Patient-Reported Outcomes in a Phase 2 Study Comparing Atezolizumab Alone or With Bevacizumab Versus Sunitinib in Previously Untreated Metastatic Renal Cell Carcinoma

scientific article published on 31 March 2020

Patterns of Declining Use and the Adverse Effect of Primary Androgen Deprivation on All-cause Mortality in Elderly Men with Prostate Cancer.

artículo científico publicado en 2014

Patterns of care for radical prostatectomy in the United States from 2003 to 2005.

artículo científico publicado en 2008

Pazopanib versus sunitinib in metastatic renal-cell carcinoma

artículo científico publicado en 2013

Pazopanib: Clinical development of a potent anti-angiogenic drug

artículo científico publicado en 2010

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.

artículo científico publicado en 2017

Pembrolizumab plus pegylated interferon alfa-2b or ipilimumab for advanced melanoma or renal cell carcinoma: dose-finding results from the phase 1b KEYNOTE-029 study

artículo científico publicado en 2018

Pharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma

artículo científico publicado en 2016

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer: a Prostate Cancer Clinical Trials Consortium trial

artículo científico publicado en 2012

Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failure

artículo científico publicado en 2011

Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma

artículo científico publicado en 2015

Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma

artículo científico publicado en 2017

Phase I Trials of Anti-ENPP3 Antibody-Drug Conjugates in Advanced Refractory Renal Cell Carcinomas

artículo científico publicado en 2018

Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma

artículo científico publicado en 2013

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma

artículo científico publicado en 2006

Plasma cell-free DNA variant analysis compared with methylated DNA analysis in renal cell carcinoma

scientific article published on 28 April 2020

Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: incidence, radiographic findings and correlation with clinical outcome

artículo científico publicado en 2012

Posttreatment Prostate Specific Antigen Nadir Predicts Prostate Cancer Specific and All Cause Mortality

artículo científico publicado en 2012

Precision medicine for metastatic renal cell carcinoma

artículo científico publicado en 2013

Predicting outcome to VEGF-targeted therapy in metastatic clear-cell renal cell carcinoma: data from recent studies

artículo científico publicado en 2008

Predictors of response to sequential sunitinib and the impact of prior VEGF-targeted drug washout in patients with metastatic clear-cell renal cell carcinoma

artículo científico publicado en 2010

Predictors, utilization patterns, and overall survival of patients undergoing metastasectomy for metastatic renal cell carcinoma in the era of targeted therapy

artículo científico publicado en 2018

Preliminary results for avelumab plus axitinib as first-line therapy in patients with advanced clear-cell renal-cell carcinoma (JAVELIN Renal 100): an open-label, dose-finding and dose-expansion, phase 1b trial.

artículo científico publicado en 2018

Prevalence of Nonrecommended Screening for Prostate Cancer and Breast Cancer in the United States: A Nationwide Survey Analysis

artículo científico publicado en 2016

Prevalence of pathogenic germline cancer risk variants in high-risk urothelial carcinoma

scientific article published on 17 December 2019

Prognostic Significance of Increases in Hemoglobin in Renal Cell Carcinoma Patients During Treatment With VEGF-directed Therapy

artículo científico publicado en 2016

Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents: results from a large, multicenter study

artículo científico publicado en 2009

Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens

artículo científico publicado en 2010

Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large phase III trial with shark cartilage extract AE 941

artículo científico publicado en 2007

Prognostic factors of survival for patients with metastatic renal cell carcinoma with brain metastases treated with targeted therapy: results from the international metastatic renal cell carcinoma database consortium

artículo científico publicado en 2013

Prognostic model for survival in patients with metastatic renal cell carcinoma: results from the international kidney cancer working group

artículo científico publicado en 2011

Prognostic significance and immune correlates of CD73 expression in renal cell carcinoma

scientific article published on 01 November 2020

Prognostic significance of bone metastases and bisphosphonate therapy in patients with renal cell carcinoma.

artículo científico publicado en 2014

Programmed death ligand-1 expression in adrenocortical carcinoma: an exploratory biomarker study

artículo científico publicado en 2015

Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy.

artículo científico publicado en 2010

Progressive immune dysfunction with advancing disease stage in renal cell carcinoma

artículo científico publicado en 2021

Prospective evaluation of analgesic use and risk of renal cell cancer

artículo científico publicado en 2011

Prostate cancer in the medicare shared savings program: are Accountable Care Organizations associated with reduced expenditures for men with prostate cancer?

scientific article published on 12 April 2019

Prostate cancer reactivates developmental epigenomic programs during metastatic progression

artículo científico publicado en 2020

Prostate-Specific Antigen Screening After 2012 US Preventive Services Task Force Recommendations

artículo científico publicado en 2015

Proton Pump Inhibitors and Survival Outcomes in Patients With Metastatic Renal Cell Carcinoma.

artículo científico publicado en 2017

Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

artículo científico publicado en 2018

Pulmonary complications with the use of mTOR inhibitors in targeted cancer therapy: a systematic review and meta-analysis.

artículo científico publicado en 2013

Quality of Care in the Treatment of Localized Intermediate and High Risk Prostate Cancer at Minority Serving Hospitals

artículo científico publicado en 2019

Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial.

artículo científico publicado en 2018

Quality-adjusted survival with first-line cabozantinib or sunitinib for advanced renal cell carcinoma in the CABOSUN randomized clinical trial (Alliance)

artículo científico publicado en 2020

RECIST 1.1 compared with RECIST 1.0 in patients with advanced renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy

artículo científico publicado en 2015

RET protein expression in papillary renal cell carcinoma

artículo científico

RNA-seq reveals aurora kinase-driven mTOR pathway activation in patients with sarcomatoid metastatic renal cell carcinoma.

artículo científico publicado en 2014

Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.

artículo científico publicado en 2016

Racial Disparities in End-of-Life Care Among Patients With Prostate Cancer: A Population-Based Study.

artículo científico publicado en 2015

Racial Disparity in Delivering Definitive Therapy for Intermediate/High-risk Localized Prostate Cancer: The Impact of Facility Features and Socioeconomic Characteristics.

artículo científico

Racial disparities in an aging population: the relationship between age and race in the management of African American men with high-risk prostate cancer.

artículo científico publicado en 2014

Racial disparities in prostate cancer-specific mortality in men with low-risk prostate cancer

artículo científico publicado en 2014

Radiogenomics in renal cell carcinoma

artículo científico publicado en 2019

Radiologic Heterogeneity in Responses to Anti-PD-1/PD-L1 Therapy in Metastatic Renal Cell Carcinoma

artículo científico publicado en 2015

Radium-223 Dichloride in Combination with Vascular Endothelial Growth Factor-Targeting Therapy in Advanced Renal Cell Carcinoma with Bone Metastases

scientific article published on 30 May 2018

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma.

artículo científico publicado en 2017

Randomized phase III trials of second-line chemotherapy in patients with advanced bladder cancer: progress and pitfalls ⬇️

artículo científico publicado el 1 de febrero de 2011

Re: Fabio Conforti, Laura Pala, Vincenzo Bagnardi, et al. Cancer Immunotherapy Efficacy and Patients' Sex: A Systematic Review and Meta-analysis. Lancet Oncol 2018;19:737-46: Outcomes of Metastatic Renal Cell Carcinoma by Gender: Contrasting Results

scientific article published on 18 July 2018

Recent advances in immunotherapy for the treatment of prostate cancer

artículo científico publicado en 2011

Recent advances in the systemic treatment of metastatic papillary renal cancer

artículo científico publicado en 2009

Recent progress and pitfalls in testing novel agents in castration-resistant prostate cancer

scientific article published on 22 July 2009

Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials

artículo científico publicado en 2010

Recommendations for the Management of Rare Kidney Cancers

artículo científico

Recurrence in Localized Renal Cell Carcinoma: a Systematic Review of Contemporary Data

artículo científico publicado en 2017

Reduced penile size and treatment regret in men with recurrent prostate cancer after surgery, radiotherapy plus androgen deprivation, or radiotherapy alone

scientific article published on January 2013

Refusal of curative radiation therapy and surgery among patients with cancer

artículo científico publicado en 2014

Renal-cell carcinoma in 2016: Advances in treatment - jostling for pole position

scientific article published on 10 January 2017

Renal-cell carcinoma: a step closer to a new classification

artículo científico publicado en 2013

Reply to Aditya Bagrodia, Solomon Woldu, David F. Penson, Alexander Kutikov, and Samuel Kaffenberger's Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage I

artículo científico publicado en 2017

Reply to B. Rini et al and S. Buti et al.

artículo científico publicado en 2017

Reply to C. Buttigliero et al and B. Biswas et al

scientific article published on 06 February 2017

Reply to Christian D. Fankhauser, Nico C. Grossmann, Joerg Beyer, and Thomas Hermanns’ Letter to the Editor re: Sophia C. Kamran, Thomas Seisen, Sarah C. Markt, et al. Contemporary Treatment Patterns and Outcomes for Clinical Stage IS Testicular Ca

artículo científico publicado en 2018

Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye

artículo científico publicado en 2014

Reply to Roberto Iacovelli, Walter Artibani, and Giampaolo Tortora's Letter to the Editor re: Ian D. Davis, Wanling Xie, Carmel Pezaro, et al. Efficacy of Second-line Targeted Therapy for Renal Cell Carcinoma According to Change from Baseline in Int

artículo científico publicado en 2016

Response of Primary Renal Cell Carcinoma to Systemic Therapy

scientific article published on 06 October 2019

Response of renal cell carcinoma pancreatic metastasis to sunitinib treatment: a retrospective analysis

artículo científico publicado en 2009

Response to single agent PD-1 inhibitor after progression on previous PD-1/PD-L1 inhibitors: a case series.

artículo científico publicado en 2017

Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features

artículo científico publicado en 2019

Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies

artículo científico publicado en 2020

Risk Assessment in Small Renal Masses: A Review Article.

artículo científico publicado en 2017

Risk Factors for New Hypothyroidism During Tyrosine Kinase Inhibitor Therapy in Advanced Nonthyroidal Cancer Patients.

artículo científico publicado en 2018

Risk factors and model for predicting toxicity-related treatment discontinuation in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy: Results from the International Metastatic Renal Cell

artículo científico publicado en 2015

Risk of Bilateral Renal Cell Cancer

artículo científico publicado en 2009

Risk of all-cause and prostate cancer-specific mortality after brachytherapy in men with small prostate size

artículo científico publicado en 2010

Risk of arterial thromboembolic events with sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

scientific article published on 29 March 2010

Risk of bleeding with vascular endothelial growth factor receptor tyrosine-kinase inhibitors sunitinib and sorafenib: a systematic review and meta-analysis of clinical trials

artículo científico publicado en 2009

Risk of dementia following androgen deprivation therapy for treatment of prostate cancer

scientific article published on 29 November 2019

Risk of prostate cancer mortality in men with a history of prior cancer

artículo científico publicado en 2015

Risk of venous thromboembolism in patients with cancer treated with Cisplatin: a systematic review and meta-analysis.

artículo científico publicado en 2012

Ruffling the Immunotherapy Response Paradigm with a Novel Personalized Peptide Vaccine

artículo científico publicado en 2016

Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma

artículo científico publicado en 2020

Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study

artículo científico publicado en 2020

Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma

artículo científico publicado en 2020

Sequencing of agents for metastatic renal cell carcinoma: can we customize therapy?

artículo científico

Severe Pazopanib-Induced Hepatotoxicity: Clinical and Histologic Course in Two Patients

artículo científico publicado en 2012

Sex specific associations in genome wide association analysis of renal cell carcinoma

scientific article published on 23 June 2019

Significant increase in prostatectomy and decrease in radiation for clinical T3 prostate cancer from 1998 to 2012.

artículo científico publicado en 2015

Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study

artículo científico publicado en 2012

Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.

artículo científico publicado en 2015

Six-month progression-free survival as the primary endpoint to evaluate the activity of new agents as second-line therapy for advanced urothelial carcinoma

artículo científico publicado en 2013

Somatic Copy Number Abnormalities and Mutations in PI3K/AKT/mTOR Pathway Have Prognostic Significance for Overall Survival in Platinum Treated Locally Advanced or Metastatic Urothelial Tumors

artículo científico publicado en 2015

Somatic ERCC2 mutations correlate with cisplatin sensitivity in muscle-invasive urothelial carcinoma

artículo científico publicado en 2014

State of the Future: Translational Approaches in Renal Cell Carcinoma in the Immunotherapy Era

artículo científico publicado en 2019

Statin use and the risk of renal cell carcinoma in 2 prospective US cohorts

artículo científico publicado en 2011

Statins and survival outcomes in patients with metastatic renal cell carcinoma

artículo científico publicado en 2015

Strategies to design clinical studies to identify predictive biomarkers in cancer research.

artículo científico publicado en 2016

Suicide and accidental deaths among patients with non-metastatic prostate cancer.

artículo científico publicado en 2015

Summary from the First Kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational Research

artículo científico publicado en 2020

Sunitinib in renal-cell carcinoma: expanded indications.

artículo científico publicado en 2009

Sunitinib rechallenge in metastatic renal cell carcinoma patients

artículo científico publicado en 2010

Sunitinib-induced macrocytosis in patients with metastatic renal cell carcinoma

artículo científico publicado en 2008

Sunitinib-induced pseudoprogression after whole-brain radiotherapy for metastatic renal cell carcinoma

artículo científico publicado en 2010

Suppression of the nitric oxide pathway in metastatic renal cell carcinoma patients receiving vascular endothelial growth factor-signaling inhibitors

artículo científico publicado en 2010

Surgeon and Hospital Level Variation in the Costs of Robot-Assisted Radical Prostatectomy

artículo científico publicado en 2016

Survey of the Impact of COVID-19 on Oncologists' Decision Making in Cancer

scientific article published on 01 August 2020

Survival Analyses of Patients With Metastatic Renal Cancer Treated With Targeted Therapy With or Without Cytoreductive Nephrectomy: A National Cancer Data Base Study.

artículo científico publicado en 2016

Survival outcome and treatment response of patients with late relapse from renal cell carcinoma in the era of targeted therapy.

artículo científico publicado en 2013

Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma: 42-month follow-up of a randomized phase 3 clinical trial

artículo científico publicado en 2020

Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome-Results from the International Metastatic Renal Cell Carcinoma Database Consortium

artículo científico publicado en 2020

Systemic Therapy for Metastatic Renal-Cell Carcinoma

artículo científico publicado en 2017

Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions

article

Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions

artículo científico publicado en 2011

Targeted genomic landscape of metastases compared to primary tumours in clear cell metastatic renal cell carcinoma

artículo científico publicado en 2018

Targeted therapies: sunitinib in RCC-expanded access equals expanded benefit?

artículo científico publicado en 2009

Targeting the HIF2-VEGF axis in renal cell carcinoma

artículo científico publicado en 2020

Temporal trends in receipt of adequate lymphadenectomy in bladder cancer 1988 to 2010.

artículo científico publicado en 2015

Testicular Cancer, Version 2.2015

artículo científico publicado en 2015

Testicular cancer

scientific article published on 01 April 2012

The Association Between Small Primary Tumor Size and Prognosis in Metastatic Renal Cell Carcinoma: Insights from Two Independent Cohorts of Patients Who Underwent Cytoreductive Nephrectomy

artículo científico publicado en 2019

The COVID-19 and Cancer Consortium: A Collaborative Effort to Understand the Effects of COVID-19 on Patients with Cancer

artículo científico publicado en 2020

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma

article

The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.

artículo científico publicado en 2018

The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non-Clear Cell Renal Cell Carcinoma

artículo científico publicado en 2018

The Clinical Presentation, Survival Outcomes, and Management of Patients With Renal Cell Carcinoma and Cardiac Metastasis Without Inferior Vena Cava Involvement: Results From a Pooled Clinical Trial Database and Systematic Review of Reported Cases.

artículo científico publicado en 2017

The Development of Brain Metastases in Patients with Renal Cell Carcinoma: Epidemiologic Trends, Survival, and Clinical Risk Factors Using a Population-based Cohort.

artículo científico publicado en 2018

The Effect of Weight Change During Treatment With Targeted Therapy in Patients With Metastatic Renal Cell Carcinoma

scientific article published on 19 July 2019

The Immune Landscape of Cancer

scientific article published on 01 August 2019

The Immune Landscape of Cancer.

artículo científico publicado en 2018

The Impact of Age and Gender on Outcomes of Patients With Advanced Renal Cell Carcinoma Treated With Targeted Therapy

scientific article published on 16 March 2020

The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study

artículo científico publicado en 2015

The Right Drug for the Right Patient: Navigating Systemic Therapy Options in Metastatic Renal Cell Carcinoma and Future Directions.

artículo científico publicado en 2015

The Use of Prostate Specific Antigen Screening in Purchased versus Direct Care Settings: Data from the TRICARE® Military Database

artículo científico

The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients

artículo científico publicado en 2013

The current role of angiogenesis inhibitors in the treatment of renal cell carcinoma

artículo científico publicado en 2006

The double edged sword of bleeding and clotting from VEGF inhibition in renal cancer patients

artículo científico

The effect of treatment at minority-serving hospitals on outcomes for bladder cancer.

artículo científico publicado en 2018

The future of perioperative therapy in advanced renal cell carcinoma: how can we PROSPER?

scientific article published on 10 April 2019

The impact of Medicare eligibility on cancer screening behaviors

artículo científico publicado en 2016

The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy

artículo científico publicado en 2010

The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy

artículo científico publicado en 2011

The impact of low serum sodium on treatment outcome of targeted therapy in metastatic renal cell carcinoma: results from the International Metastatic Renal Cell Cancer Database Consortium

artículo científico publicado en 2013

The influence of marital status on the use of breast, cervical, and colorectal cancer screening

artículo científico publicado en 2016

The influence of obesity-related factors in the etiology of renal cell carcinoma-A mendelian randomization study ⬇️

scientific article published on 03 January 2019

The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma.

artículo científico publicado en 2013

The role of site-specific therapy for cancers of unknown of primary: A meta-analysis

artículo científico publicado en 2020

The somatic genomic landscape of chromophobe renal cell carcinoma

artículo científico publicado en 2014

Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis

artículo científico publicado en 2011

Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

artículo científico publicado en 2016

Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials

artículo científico publicado en 2013

Time to prostate-specific antigen nadir independently predicts overall survival in patients who have metastatic hormone-sensitive prostate cancer treated with androgen-deprivation therapy

artículo científico publicado en 2009

Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025.

artículo científico

Treatment of Advanced Renal-Cell Carcinoma

artículo científico publicado en 2016

Treatment selection for patients with metastatic renal cell carcinoma

artículo científico publicado en 2009

Trebananib (AMG 386) in Combination With Sunitinib in Patients With Metastatic Renal Cell Cancer: An Open-Label, Multicenter, Phase II Study.

artículo científico publicado en 2015

Trends in disparate treatment of African American men with localized prostate cancer across National Comprehensive Cancer Network risk groups

artículo científico publicado en 2014

Tumor Mutational Load and Immune Parameters across Metastatic Renal Cell Carcinoma Risk Groups

artículo científico publicado en 2016

Tumor control with PD-1 inhibition in a patient with concurrent metastatic melanoma and renal cell carcinoma

artículo científico publicado en 2016

Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

artículo científico publicado en 2016

Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non-Lymph Node Distant Metastasis.

artículo científico publicado en 2017

Use of Preventive Health Services Among Cancer Survivors in the U.S

article

Use of surveillance imaging following treatment of small renal masses

artículo científico publicado en 2013

Utilization and expense of adjuvant cancer therapies following radical prostatectomy

artículo científico publicado en 2011

Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: A COVID-19 and Cancer Consortium (CCC19) cohort study

artículo científico publicado en 2020

Validation and genomic interrogation of the MET variant rs11762213 as a predictor of adverse outcomes in clear cell renal cell carcinoma

artículo científico publicado en 2015

Variation in National Use of Long-Term ADT by Disease Aggressiveness Among Men With Unfavorable-Risk Prostate Cancer

artículo científico publicado en 2016

Variation in the use of active surveillance for low-risk prostate cancer.

artículo científico publicado en 2017

Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA

artículo científico publicado en 2017

Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma

artículo científico publicado en 2010

Venous thromboembolic events with vascular endothelial growth factor receptor tyrosine kinase inhibitors: a systematic review and meta-analysis of randomized clinical trials

artículo científico

Vinflunine: drug safety evaluation of this novel synthetic vinca alkaloid

artículo científico publicado en 2011

Weight gain on androgen deprivation therapy: which patients are at highest risk?

artículo científico publicado en 2014

Which patients with undetectable PSA levels 5 years after radical prostatectomy are still at risk of recurrence?--implications for a risk-adapted follow-up strategy

artículo científico publicado en 2010

Who bears the greatest burden of aggressive treatment of indolent prostate cancer?

artículo científico publicado en 2015

Whole-Exome Sequencing in Two Extreme Phenotypes of Response to VEGF-Targeted Therapies in Patients With Metastatic Clear Cell Renal Cell Carcinoma

artículo científico publicado en 2016

irRECIST for the Evaluation of Candidate Biomarkers of Response to Nivolumab in Metastatic Clear Cell Renal Cell Carcinoma: Analysis of a Phase II Prospective Clinical Trial

scientific article published on 22 January 2019

von Hippel-Lindau gene status and response to vascular endothelial growth factor targeted therapy for metastatic clear cell renal cell carcinoma

artículo científico publicado en 2008

¹¹C-methionine positron-emission tomography and computed tomography (PET-CT) in evaluating metastatic transitional cell carcinoma response to sunitinib therapy

artículo científico publicado en 2010

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda